BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 855 filers reported holding BAXTER INTL INC in Q3 2013. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $769,896 | -17.2% | 20,400 | 0.0% | 0.04% | -11.8% |
| Q2 2023 | $929,424 | +12.3% | 20,400 | 0.0% | 0.05% | +6.2% |
| Q1 2023 | $827,424 | +79460.0% | 20,400 | 0.0% | 0.05% | -17.2% |
| Q4 2022 | $1,040 | -99.9% | 20,400 | +14.0% | 0.06% | -4.9% |
| Q3 2022 | $964,000 | -16.8% | 17,900 | -0.7% | 0.06% | -14.1% |
| Q2 2022 | $1,158,000 | -17.2% | 18,025 | 0.0% | 0.07% | -2.7% |
| Q1 2022 | $1,398,000 | -9.9% | 18,025 | -0.3% | 0.07% | -7.6% |
| Q4 2021 | $1,552,000 | +6.7% | 18,075 | 0.0% | 0.08% | -1.2% |
| Q3 2021 | $1,454,000 | -0.1% | 18,075 | 0.0% | 0.08% | -1.2% |
| Q2 2021 | $1,455,000 | +4.1% | 18,075 | +9.0% | 0.08% | +1.2% |
| Q1 2021 | $1,398,000 | +17.5% | 16,575 | +11.8% | 0.08% | +12.7% |
| Q4 2020 | $1,190,000 | +15.0% | 14,825 | -41.2% | 0.07% | -19.3% |
| Q1 2016 | $1,035,000 | +1.3% | 25,195 | -6.0% | 0.09% | -1.1% |
| Q4 2015 | $1,022,000 | -71.7% | 26,795 | -75.6% | 0.09% | -73.0% |
| Q3 2015 | $3,613,000 | -54.5% | 109,995 | -3.1% | 0.33% | -49.5% |
| Q2 2015 | $7,934,000 | -8.5% | 113,459 | -10.4% | 0.65% | -2.8% |
| Q1 2015 | $8,672,000 | +19.1% | 126,604 | +24.7% | 0.67% | -18.9% |
| Q3 2014 | $7,284,000 | +13.4% | 101,495 | +16.2% | 0.83% | +13.5% |
| Q1 2014 | $6,425,000 | +10.3% | 87,321 | +4.3% | 0.73% | +8.3% |
| Q4 2013 | $5,825,000 | +4.5% | 83,757 | +4.1% | 0.68% | -10.4% |
| Q2 2013 | $5,572,000 | – | 80,442 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |